1. Chronobiology's progress. Part II, chronomics for an immediately applicable biomedicine
- Author
-
Franz Halberg, Germaine Cornélissen, George Katinas, Levan Tvildiani, Marina Gigolashvili, Ketevan Janashia, Tim Toba, Miguel Revilla, Philip Regal, Robert B. Sothern, Hans W. Wendt, Zhengrong Wang, Michal Zeman, Rita Jozsa, R.B. Singh, Gen Mitsutake, Sergei M. Chibisov, Jong Lee, Dan Holley, James E. Holte, Robert P. Sonkowsky, Othild Schwartzkopff, Patrick Delmore, Kuniaki Otsuka, Earl E. Bakken, Jerzy Czaplicki, and the International BIOCOS Group
- Subjects
medicine.medical_specialty ,Chronobiology ,General Immunology and Microbiology ,business.industry ,General Neuroscience ,Health, Toxicology and Mutagenesis ,Biomedical Engineering ,General Medicine ,Disease ,General Biochemistry, Genetics and Molecular Biology ,Food restriction ,Increased risk ,Blood pressure ,Artificial Intelligence ,Disease risk ,Medicine ,Circadian rhythm ,General Pharmacology, Toxicology and Pharmaceutics ,General Agricultural and Biological Sciences ,business ,Intensive care medicine ,Biomedicine - Abstract
Chronomic cardiovascular surveillance serves to recognise and treat any risk elevation as well as overt disease, and to ascertain whether treatment is effective and, if so, for how long treatment effects lasts, be it for lowering an increased risk and/or in surveilling the success or failure of treatment. A treatment-associated increase in circadian amplitude of blood pressure (BP) may induce iatrogenic overswinging, also dubbed CHAT ( circadian hyper- amplitude- tension), in some patients, thereby increasing cardiovascular disease risk unknowingly to care provider and receiver.
- Published
- 2006
- Full Text
- View/download PDF